ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Upcoming Investor Conferences  
9/4/2013 7:03:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its proprietary antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

•Morgan Stanley Global Healthcare Conference 9:10 am ET, September 11 in New York, NY

Help employers find you! Check out all the jobs and post your resume.